Cochrane Abstracts
Vigabatrin add‐on therapy for drug‐resistant focal epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vigabatrin Add‐on Therapy for Drug‐resistant Focal Epilepsy." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435056/all/Vigabatrin_add‐on_therapy_for_drug‐resistant_focal_epilepsy. Accessed 23 September 2023.
Vigabatrin add‐on therapy for drug‐resistant focal epilepsy. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435056/all/Vigabatrin_add‐on_therapy_for_drug‐resistant_focal_epilepsy. Accessed September 23, 2023.
Vigabatrin add‐on therapy for drug‐resistant focal epilepsy. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435056/all/Vigabatrin_add‐on_therapy_for_drug‐resistant_focal_epilepsy
Vigabatrin Add‐on Therapy for Drug‐resistant Focal Epilepsy [Internet]. In: Cochrane Abstracts. [cited 2023 September 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435056/all/Vigabatrin_add‐on_therapy_for_drug‐resistant_focal_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vigabatrin add‐on therapy for drug‐resistant focal epilepsy
ID - 435056
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435056/all/Vigabatrin_add‐on_therapy_for_drug‐resistant_focal_epilepsy
DB - Evidence Central
DP - Unbound Medicine
ER -
